Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1960 1
1969 1
1972 1
1973 1
1974 3
1975 2
1976 4
1977 3
1978 1
1979 1
1980 5
1981 2
1982 4
1983 3
1985 2
1987 4
1989 3
1990 2
1991 4
1992 12
1993 3
1994 13
1995 9
1996 11
1997 10
1998 8
1999 18
2000 18
2001 16
2002 12
2003 5
2004 11
2005 11
2006 10
2007 9
2008 15
2009 18
2010 10
2011 9
2012 12
2013 23
2014 21
2015 20
2016 23
2017 15
2018 24
2019 23
2020 25
2021 25
2022 22
2023 21
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

479 results

Results by year

Filters applied: . Clear all
Page 1
Crowned dens syndrome.
Yamada T, Saitoh T, Hozumi H, Takahashi Y, Nozawa M, Mochizuki T, Yoshino A. Yamada T, et al. Among authors: nozawa m. Acute Med Surg. 2015 Jan 7;2(4):273. doi: 10.1002/ams2.98. eCollection 2015 Oct. Acute Med Surg. 2015. PMID: 29123739 Free PMC article. No abstract available.
Real-world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST-NIVO study): 36-month follow-up results of a clinical chart review.
Yonese J, Hinata N, Masui S, Nakai Y, Shirotake S, Takeuchi A, Inamoto T, Nozawa M, Ueda K, Etsunaga T, Osawa T, Uemura M, Kimura G, Numakura K, Yamana K, Miyake H, Fukasawa S, Morishima N, Ito H, Uemura H. Yonese J, et al. Among authors: nozawa m. Int J Urol. 2023 Sep;30(9):762-771. doi: 10.1111/iju.15206. Epub 2023 May 29. Int J Urol. 2023. PMID: 37248753
HOXA10 expression profiling in prostate cancer.
Hatanaka Y, de Velasco MA, Oki T, Shimizu N, Nozawa M, Yoshimura K, Yoshikawa K, Nishio K, Uemura H. Hatanaka Y, et al. Among authors: nozawa m. Prostate. 2019 Apr;79(5):554-563. doi: 10.1002/pros.23761. Epub 2019 Jan 6. Prostate. 2019. PMID: 30614022
The neutral theory of molecular evolution in the genomic era.
Nei M, Suzuki Y, Nozawa M. Nei M, et al. Among authors: nozawa m. Annu Rev Genomics Hum Genet. 2010;11:265-89. doi: 10.1146/annurev-genom-082908-150129. Annu Rev Genomics Hum Genet. 2010. PMID: 20565254 Review.
Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial.
Shiota M, Miyake H, Takahashi M, Oya M, Tsuchiya N, Masumori N, Matsuyama H, Obara W, Shinohara N, Fujimoto K, Nozawa M, Ohba K, Ohyama C, Hashine K, Akamatsu S, Kamba T, Mita K, Gotoh M, Tatarano S, Fujisawa M, Tomita Y, Mukai S, Ito K, Tanegashima T, Tokunaga S, Eto M; SNiP-RCC investigators. Shiota M, et al. Among authors: nozawa m. Cancer Immunol Immunother. 2023 Jun;72(6):1903-1915. doi: 10.1007/s00262-023-03367-w. Epub 2023 Feb 2. Cancer Immunol Immunother. 2023. PMID: 36729213
Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP-RCC study.
Blas L, Shiota M, Miyake H, Takahashi M, Oya M, Tsuchiya N, Masumori N, Matsuyama H, Obara W, Shinohara N, Fujimoto K, Nozawa M, Ohba K, Ohyama C, Hashine K, Akamatsu S, Kamba T, Mita K, Gotoh M, Tatarano S, Fujisawa M, Tomita Y, Mukai S, Ito K, Tanegashima T, Tokunaga S, Eto M; SNiP-RCC Investigators. Blas L, et al. Among authors: nozawa m. Int J Urol. 2023 Sep;30(9):788-796. doi: 10.1111/iju.15265. Epub 2023 Aug 1. Int J Urol. 2023. PMID: 37528632
Recurrent abdominal pain caused by nephroptosis.
Yoshida S, Matsumura M, Maekawa K, Minaga K, Kamata K, Nozawa M, Watanabe T, Kudo M. Yoshida S, et al. Among authors: nozawa m. Clin J Gastroenterol. 2020 Aug;13(4):621-625. doi: 10.1007/s12328-020-01110-x. Epub 2020 Feb 28. Clin J Gastroenterol. 2020. PMID: 32112340
Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma.
Nakaigawa N, Tomita Y, Tamada S, Tatsugami K, Osawa T, Oya M, Kanayama H, Miura Y, Sassa N, Nishimura K, Nozawa M, Masumori N, Miyoshi Y, Kuroda S, Kimura A. Nakaigawa N, et al. Among authors: nozawa m. Int J Clin Oncol. 2023 Mar;28(3):416-426. doi: 10.1007/s10147-022-02283-w. Epub 2023 Jan 3. Int J Clin Oncol. 2023. PMID: 36595123 Free PMC article. Clinical Trial.
479 results